Natco Pharma Limited Asset Resilience Ratio

Latest as of September 2025: 63.89%

Natco Pharma Limited asset resilience ratio. Natco Pharma Limited (NATCOPHARM) has an Asset Resilience Ratio of 63.89% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Natco Pharma Limited defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

Rs66.64 Billion

≈ $720.63 Million USD Cash + Short-term Investments

Total Assets

Rs104.30 Billion

≈ $1.13 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Natco Pharma Limited (2005–2025)

Asset resilience ratio of Natco Pharma Limited from 2005 to 2025. This chart shows how Natco Pharma Limited's Asset Resilience Ratio has changed over time. Read total liabilities of Natco Pharma Limited for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Natco Pharma Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Natco Pharma Limited asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs26.90 Billion	25.79%
Short-term Investments	Rs39.73 Billion	38.09%
Total Liquid Assets	Rs66.64 Billion	63.89%

Asset Resilience Insights

Very High Liquidity: Natco Pharma Limited maintains exceptional liquid asset reserves at 63.89% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Natco Pharma Limited Industry Peers by Asset Resilience Ratio

Compare Natco Pharma Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Changchun High & New Technology Industries Group Inc SHE:000661	Drug Manufacturers - Specialty & Generic	5.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Porton Fine Chemicals Ltd SHE:300363	Drug Manufacturers - Specialty & Generic	6.85%
Jubilant Pharmova Limited NSE:JUBLPHARMA	Drug Manufacturers - Specialty & Generic	1.26%

Natco Pharma Limited Asset Resilience Ratio by Year (2005–2025)

Natco Pharma Limited asset resilience ratio by year from 2005 to 2025. The table below shows the annual Asset Resilience Ratio data for Natco Pharma Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	31.76%	Rs27.41 Billion ≈ $296.48 Million	Rs86.31 Billion ≈ $933.39 Million	+6.95pp
2024-03-31	24.82%	Rs17.14 Billion ≈ $185.36 Million	Rs69.06 Billion ≈ $746.89 Million	-0.06pp
2023-03-31	24.88%	Rs14.07 Billion ≈ $152.19 Million	Rs56.57 Billion ≈ $611.83 Million	+12.18pp
2022-03-31	12.70%	Rs6.49 Billion ≈ $70.17 Million	Rs51.09 Billion ≈ $552.53 Million	-3.83pp
2021-03-31	16.53%	Rs7.92 Billion ≈ $85.64 Million	Rs47.92 Billion ≈ $518.23 Million	-2.71pp
2020-03-31	19.24%	Rs8.83 Billion ≈ $95.46 Million	Rs45.88 Billion ≈ $496.15 Million	-4.68pp
2019-03-31	23.92%	Rs10.29 Billion ≈ $111.31 Million	Rs43.03 Billion ≈ $465.36 Million	+1.72pp
2018-03-31	22.20%	Rs8.25 Billion ≈ $89.18 Million	Rs37.15 Billion ≈ $401.77 Million	+17.29pp
2017-03-31	4.91%	Rs1.14 Billion ≈ $12.30 Million	Rs23.18 Billion ≈ $250.64 Million	+3.76pp
2016-03-31	1.15%	Rs209.64 Million ≈ $2.27 Million	Rs18.24 Billion ≈ $197.24 Million	+1.14pp
2015-03-31	0.01%	Rs1.18 Million ≈ $12.79K	Rs13.84 Billion ≈ $149.68 Million	-0.02pp
2014-03-31	0.03%	Rs3.18 Million ≈ $34.39K	Rs11.96 Billion ≈ $129.31 Million	-0.05pp
2013-03-31	0.08%	Rs8.12 Million ≈ $87.83K	Rs10.80 Billion ≈ $116.84 Million	-0.01pp
2012-03-31	0.08%	Rs7.37 Million ≈ $79.76K	Rs9.03 Billion ≈ $97.63 Million	-9.70pp
2011-03-31	9.78%	Rs691.96 Million ≈ $7.48 Million	Rs7.07 Billion ≈ $76.49 Million	+1.43pp
2010-03-31	8.36%	Rs460.41 Million ≈ $4.98 Million	Rs5.51 Billion ≈ $59.58 Million	-8.29pp
2009-03-31	16.65%	Rs859.93 Million ≈ $9.30 Million	Rs5.17 Billion ≈ $55.86 Million	+2.77pp
2008-03-31	13.88%	Rs581.93 Million ≈ $6.29 Million	Rs4.19 Billion ≈ $45.36 Million	-2.82pp
2007-03-31	16.69%	Rs583.87 Million ≈ $6.31 Million	Rs3.50 Billion ≈ $37.83 Million	+2.74pp
2006-03-31	13.95%	Rs429.69 Million ≈ $4.65 Million	Rs3.08 Billion ≈ $33.30 Million	-1.36pp
2005-03-31	15.31%	Rs439.99 Million ≈ $4.76 Million	Rs2.87 Billion ≈ $31.08 Million	--

pp = percentage points

About Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$1.56 Billion

Rs144.54 Billion INR

Market Cap Rank

#6817 Global

#332 in India

Share Price

Rs807.00

Change (1 day)

+1.31%

52-Week Range

Rs781.60 - Rs1206.00

All Time High

Rs1591.09